CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,976,580
- in 4 filings, $5.0M under 10b5-1 plans
Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-18 | DAWES KAREN A Director | Sale | −122 | $139.32 | $17K | 120,293 |
| 2020-05-18 | DAWES KAREN A Director | Sale | −180 | $140.62 | $25K | 120,113 |
| 2020-05-18 | DAWES KAREN A Director | Sale | −77 | $141.45 | $11K | 120,036 |
| 2020-05-18 | DAWES KAREN A Director | Sale | −80 | $142.45 | $11K | 119,956 |
| 2020-05-15 | KURIYEL RALF Senior VP, R&D | Sale | −435 | $140.69 | $61K | 26,089 |
| 2020-05-15 | Snodgres Jon Chief Financial Officer | Sale | −660 | $140.43 | $93K | 32,267 |
| 2020-05-13 | DAWES KAREN A Director | Grant or award | +722 | 121,556 | ||
| 2020-05-13 | DAWES KAREN A Director | Grant or award · Stock Option (Right to Buy) | +1,761 | 1,761 | ||
| 2020-05-13 | DAWES KAREN A Director | Grant or award | +722 | 121,556 | ||
| 2020-05-13 | DAWES KAREN A Director | Grant or award · Stock Option (Right to Buy) | +1,761 | 1,761 | ||
| 2020-05-13 | RYAN THOMAS F JR Director | Grant or award | +527 | 2,450 | ||
| 2020-05-13 | RYAN THOMAS F JR Director | Grant or award · Stock Option (Right to Buy) | +1,285 | 1,285 | ||
| 2020-05-13 | BARTHELEMY NICOLAS Director | Grant or award | +527 | 3,564 | ||
| 2020-05-13 | BARTHELEMY NICOLAS Director | Grant or award · Stock Option (Right to Buy) | +1,285 | 1,285 | ||
| 2020-05-13 | MUIR GLENN P Director | Grant or award | +527 | 5,905 | ||
| 2020-05-13 | MUIR GLENN P Director | Grant or award · Stock Option (Right to Buy) | +1,285 | 1,285 | ||
| 2020-05-13 | Snodgres Jon Chief Financial Officer | Exercise or conversion | +3,170 | $26.05 | $83K | 39,297 |
| 2020-05-13 | Snodgres Jon Chief Financial Officer | Exercise or conversion | +9,024 | $32.40 | $292K | 48,321 |
| 2020-05-13 | Snodgres Jon Chief Financial Officer | Sale | −5,358 | $126.77 | $679K | 42,963 |
| 2020-05-13 | Snodgres Jon Chief Financial Officer | Sale | −2,865 | $127.75 | $366K | 40,098 |
Page 35 of 42 · 832 trades